The PRIME-XS consortium provides an infrastructure of state-of-the-art proteomics technology to the biological and biomedical research community in Europe.
Its twelve partners, all leading in the field of proteomics, provide subsidized access to their technology at six access facilities, distributed over Europe. In addition, the partners in the consortium develop new technologies to better aid the research community in answering current day scientific questions, and organize a wide range of meetings, courses and training events. The project is funded under the 7th Framework Programme of the European Union (Contract no. 262067- PRIME-XS)